Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study

Background Although TNF inhibitors are well established in ankylosing spondylitis treatment, the majority of studies on TNF inhibitors safety have been performed in rheumatoid arthritis patients. Meanwhile, it seems that TNF inhibitors in ankylosing spondylitis may present a better safety profile th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wroński, Jakub, Fiedor, Piotr, Głuszko, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677866/
https://www.ncbi.nlm.nih.gov/pubmed/31172410
http://dx.doi.org/10.1007/s11096-019-00859-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677866/
https://www.ncbi.nlm.nih.gov/pubmed/31172410
http://dx.doi.org/10.1007/s11096-019-00859-7

Ejemplares similares